Bank of New York Mellon’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.25M | Buy |
|
|||||
|
2025
Q2 | $2.69M | Sell |
|
|||||
|
2025
Q1 | $2.67M | Buy |
|
|||||
|
2024
Q4 | $3.77M | Buy |
|
|||||
|
2024
Q3 | $3.89M | Sell |
|
|||||
|
2024
Q2 | $2.71M | Buy |
|
|||||
|
2024
Q1 | $2.66M | Buy |
|
|||||
|
2023
Q4 | $3.26M | Buy |
|
|||||
|
2023
Q3 | $2.12M | Sell |
|
|||||
|
2023
Q2 | $3.38M | Buy |
|
|||||
|
2023
Q1 | $3.55M | Sell |
|
|||||
|
2022
Q4 | $4.46M | Buy |
|
|||||
|
2022
Q3 | $1.85M | Buy |
|
|||||
|
2022
Q2 | $802K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $15K | Sell |
|
|||||
|
2019
Q2 | $65K | Sell |
|
|||||
|
2019
Q1 | $289K | Buy |
|
|||||
|
2018
Q4 | $302K | Buy |
|
|||||
|
2018
Q3 | $350K | Buy |
|
|||||
|
2018
Q2 | $384K | Buy |
|
|||||
|
2018
Q1 | $248K | Sell |
|
|||||
|
2017
Q4 | $478K | Buy |
|
|||||
|
2017
Q3 | $250K | Sell |
|
|||||
|
2017
Q2 | $355K | Buy |
|